F-group (family)
6.1.1.3 IL1
Ligands and drugs
216
Member domains
58
with ligand contacts (≤ 4 Å)
26.9% of members
52
with DrugDomain annotations
24.1% of members
44
with a DrugBank compound
20.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 6.1.1.3 belongs to X-group 6 beta-Trefoil, which binds 7.5 ligand superclasses per 20 proteins, narrower than 52% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 2 |
| DB00843 | — | — | 1 |
| DB01017 | — | Minocycline | 1 |
| DB05260 | — | — | 1 |
| DB05412 | — | Talmapimod | 1 |
| DB05442 | — | — | 1 |
| DB05470 | — | — | 1 |
| DB05767 | — | — | 1 |
| DB08155 | M25 | N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE | 1 |
| DB08578 | SX2 | 4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid | 1 |
| DB11967 | — | Binimetinib | 1 |
| DB12140 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| A1H4A | 8-[4-methyl-3-(trifluoromethyl)phenyl]-2-[[(7S)-7-(2-morpholin-4-ylethylcarbamoyl)-4-(phenylsulfonyl)-1,4-diazepan-1-yl]carbonyl]imidazo[1,2-a]pyridine-6-carboxylic acid | 4 |
| CPS | 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE | 4 |
| CL | CHLORIDE ION | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| S8D | 2-[(2~{R},5~{S})-2,5-dimethylmorpholin-4-yl]-~{N}-ethyl-ethanamide | 2 |
| T9C | (S)-4'-hydroxy-3'-(6-methyl-2-oxo-3-(1H-pyrazol-4-yl)indolin-3-yl)-[1,1'-biphenyl]-2,4-dicarboxylic acid | 2 |
| A7N | (1~{R})-1-(4-ethoxyphenyl)ethanamine | 1 |
| GT4 | ~{N}-(4-hydroxyphenyl)-2-methoxy-ethanamide | 1 |
| JGY | 1-methyl-N-{[(2S)-oxolan-2-yl]methyl}-1H-pyrazole-3-carboxamide | 1 |
| K0G | N-phenyl-N'-pyridin-3-ylurea | 1 |
| K34 | 5-(1,3-thiazol-2-yl)-1H-1,2,4-triazole | 1 |
| K3Y | 1-methyl-3-[(3R)-piperidin-3-yl]-1H-pyrazole-4-carboxamide | 1 |
| LWA | (2~{S})-~{N}-(4-aminocarbonylphenyl)oxolane-2-carboxamide | 1 |
| M25 | N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE | 1 |
| NAmetal | SODIUM ION | 1 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 1 |
| NY4 | N-{4-[(1S)-1-aminoethyl]phenyl}cyclopropanecarboxamide | 1 |
| O6D | (2S)-2-{[4-(3-amino-4-methylphenyl)-6-methylpyrimidin-2-yl]oxy}-3-methoxy-3,3-diphenylpropanoic acid | 1 |
| OGE | 1-(5-bromanylpyridin-2-yl)-3-(2-hydroxyethyl)urea | 1 |
| S7A | 3,3,3-tris(fluoranyl)-1-piperazin-1-yl-propan-1-one | 1 |